about
'Ideal criteria' for starting chronic hemodialysis: numbers, symptoms or an alerting 'traffic light' system?Laboratory markers of ventricular arrhythmia risk in renal failureValue of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD)Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs).Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation.Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney diseaseAssociates of cardiopulmonary arrest in the perihemodialytic period.Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients.Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.Omega-3 polyunsaturated Fatty acids and heart rate variability.Detection of autonomic dysfunction in hemodialysis patients using the exercise treadmill test: the role of the chronotropic index, heart rate recovery, and R-R variabilityPredictors of sudden cardiac death: a competing risk approach in the hemodialysis studyElectrocardiogram abnormalities and heart rate variability in predicting mortality and cardiovascular events among hemodialyzed patients.Heart Rate Variability Correlates to Functional Aerobic Impairment in Hemodialysis Patients.Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis.Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns StudyElectrocardiographic Abnormalities and QTc Interval in Patients Undergoing Hemodialysis.Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial.Cholinergic anti-inflammatory pathway activity in dialysis patients: a role for neuroimmunomodulation?Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.Heritability of Risk for Sudden Cardiac Arrest in ESRD.Usefulness of measurement of heart rate variability by holter ECG in hemodialysis patients.Predictors of Arrhythmic Events Detected by Implantable Loop Recorders in Renal Transplant Candidates.Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.Landmark Prediction of Long Term Survival Incorporating Short Term Event Time InformationInfluence of renal function on mortality and ventricular arrhythmias in patients undergoing first implantable cardioverter-defibrillator generator replacement.Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease.Predictors of heart rate variability and its prognostic significance in chronic kidney disease.Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis StudyHeart rhythm complexity impairment in patients undergoing peritoneal dialysisChanges in QT interval before and after hemodialysisAnemia, diabetes, and chronic kidney disease.Association between Clinical and Doppler Echocardiographic Parameters with Sudden Death in Hemodialysis Patients.Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.Statins in patients with chronic kidney disease: why, who and when?
P2860
Q26825807-058E358B-9455-4F9A-8A3D-30ED11663196Q27004652-BACF1B02-B849-4CCF-B077-9EB484F75053Q28067809-3F581558-6202-42EA-AA8B-8013408F41C7Q31076633-69DBB364-B27D-45DF-9FDF-DB70EF78251CQ33921094-2A9DA356-6DD8-4566-9653-FD5C43D1D7B2Q33975412-8D580AEA-03B1-4ED7-88E7-C7C1357DA498Q34203721-108FD85B-4004-4B3B-8153-0B2280A5001BQ34281471-378175CD-76DA-4E6A-A99D-45552D3426D9Q34532711-959FE083-92E2-409A-AB25-DF1E606C28CBQ34572435-449BB52E-B18A-4B87-8378-7A5063677745Q34770416-E6CE626E-8B02-428C-A3D4-024DC6431D8CQ34820403-5ED64F91-53B1-4826-BECD-C143471BA949Q35210010-8E524746-5F9E-4A6B-966D-DE55B5E2E436Q35552894-288279BB-AD11-497B-8723-974320219A1CQ35652577-66733C22-A620-4EA7-978E-164EF1BEDE47Q35692508-479770F9-3F95-4E4A-95E9-F1A3F6F4CE4FQ35761655-8C3CE24B-B754-44F7-A9AC-6E9CED85DDE9Q35794582-5AF90BB7-D2C0-47A5-BF48-767A93934633Q35909295-CABCF608-1616-443B-BE4D-C47CA9D2A1D5Q35917414-8D725873-15FC-4F37-8D0B-3807CC1F5821Q36015708-AE5753EF-4355-4195-8B1C-A8F263EC2E48Q36071494-18C1C06C-903C-429E-8E52-A7E52F94E8E5Q36088882-1A9A25D5-6E53-4626-B9F2-4FE5C02E8852Q36127512-8E3B7FD3-1D1A-4C3A-93D2-A30AE06AC32AQ36223335-817F9D24-FBFD-4288-8516-BD8EC92B281CQ36241025-E9393482-3E59-4428-B789-E8E0B9BE976BQ36295799-7B669605-9EE1-4786-89B2-E7669AB47B42Q36443751-04AF992C-343C-4D17-BF35-B68BAFDF5D1DQ36503235-D902785F-9F0C-407A-9627-FC00806A74CFQ36543635-07C38292-EE45-4A7C-B4AD-0CC9ACCE3B2BQ36729003-4A1554B6-FCC8-45BF-8CE5-70960C9DB83CQ36740979-DD259A39-E685-49AE-948A-81B4D26B5E2BQ36770929-A6F28A38-5823-40A4-BE1B-7D20403D78BEQ37024090-BB7C54C0-2E69-4C8C-AE9B-BAC3238F2811Q37145242-97F0B72D-3ABC-41F1-A557-256896B0D09AQ37235968-4EF1D18F-F9CD-4068-9DC1-03396515020FQ37357070-86A6D6B8-BFBB-4232-8592-6B67DCEF4849Q37702722-884FC903-EF1E-4D96-AE64-709F126A1D4DQ37738896-9C97BAFA-800B-4110-B5CB-346975CFAD70Q37803236-A418269E-ADF7-410C-A73A-5783FC8D8D58
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sudden cardiac death and dialysis patients.
@en
Sudden cardiac death and dialysis patients.
@nl
type
label
Sudden cardiac death and dialysis patients.
@en
Sudden cardiac death and dialysis patients.
@nl
prefLabel
Sudden cardiac death and dialysis patients.
@en
Sudden cardiac death and dialysis patients.
@nl
P2093
P2860
P1433
P1476
Sudden cardiac death and dialysis patients.
@en
P2093
Charles A Herzog
J Michael Mangrum
Rod Passman
P2860
P304
P356
10.1111/J.1525-139X.2008.00455.X
P577
2008-07-08T00:00:00Z